Expanded Access Protocol of ZULRESSO™ (Brexanolone) Injection for Adult Patients With Postpartum Depression
Clinical trial NCT03924492 · APPROVED_FOR_MARKETING
Trial details
- NCT number
- NCT03924492
- Sponsor
- Supernus Pharmaceuticals, Inc.
- Status
- APPROVED_FOR_MARKETING
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.